Clinical Trials in Daqing, Heilongjiang
23 recruiting
Showing 1–20 of 21 trials
Recruiting
Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy (IgAN)
Biogen454 enrolled233 locationsNCT06935357
Recruiting
Phase 3
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Biogen180 enrolled93 locationsNCT06962800
Recruiting
Phase 2
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd300 enrolled28 locationsNCT05686642
Recruiting
Phase 3
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
AIS
Biocells (Beijing) Biotech Co.,Ltd1,112 enrolled9 locationsNCT07520565
Recruiting
Phase 3
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.566 enrolled70 locationsNCT07165951
Recruiting
Phase 3
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.246 enrolled60 locationsNCT07107256
Recruiting
Phase 2
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Acute Ischemic Stroke
Kunming Pharmaceuticals, Inc.300 enrolled23 locationsNCT07279493
Recruiting
Phase 4
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Cardiac dysfunctionCoronary Heart Disease
SPH Qingdao Growful Pharmacetical Co.,Ltd2,708 enrolled96 locationsNCT07110415
Recruiting
Phase 3
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
Hyperkalemia
Waterstone Pharmaceutical (Wuhan) Co., LTD.420 enrolled50 locationsNCT07251309
Recruiting
Effects of Prior Induced Termination of Pregnancy on Complications and Pregnancy Outcomes.
Reproductive HealthAbortion
National Research Institute for Family Planning, China20,000 enrolled12 locationsNCT04183829
Recruiting
Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
Adverse EventAcute Myocardial Infarction
Yu Bo15,000 enrolled18 locationsNCT05862103
Recruiting
Phase 2
Efficacy and Safety of SR1375 in Adult Patients With CAP
Community-acquired Pneumonia
Shanghai SIMR Biotechnology Co., Ltd.240 enrolled29 locationsNCT06577558
Recruiting
Phase 3
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Asthma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.660 enrolled74 locationsNCT06829784
Recruiting
Phase 3
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.518 enrolled71 locationsNCT05922345
Recruiting
Phase 3
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
MyopiaMyopia Progression
Oupushifang Pharmaceutical Technology Co., Ltd.606 enrolled25 locationsNCT06708156
Recruiting
Phase 3
Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
Hyperplasia of Mammary Glands
Tasly Pharmaceutical Group Co., Ltd430 enrolled27 locationsNCT06685978
Recruiting
Not Applicable
Construction of a Risky Sexual Behaviour Intervention Programme for College Students Based on BCW Theory
Unsafe Sex
Rong Zhang40 enrolled1 locationNCT06435234
Recruiting
Not Applicable
Effects of Appropriate Technology for Home-based Rehabilitation in Patients With Post-stroke Physical Dysfunction
Stroke
Xi Chen72 enrolled1 locationNCT06437587
Recruiting
Phase 2
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Beijing InnoCare Pharma Tech Co., Ltd.186 enrolled41 locationsNCT05688696
Recruiting
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269